By educating and empowering patients and their families, clinicians can help improve access to accurate diagnoses and care for women…
Articles by Marisa Horak, MS
Treatment disruptions during the height of the COVID-19 pandemic were a substantial driver of psychological distress for people with…
Hemophilia A patients rack up high hospital bills, driving costs for the healthcare system higher, a study from Canada…
A branch of the European Medicines Agency (EMA) has recommended that the experimental therapy denecimig be approved to treat…
In children with severe hemophilia A who are undergoing treatment to remove inhibitors, adding Hemlibra (emicizumab-KXWH) was associated…
Alvotech and Lotus Pharmaceutical are teaming up on plans to commercialize AVT87, a proposed biosimilar to Hemlibra…
Upfront treatment with Hemlibra (emicizumab-KXWH) may help reduce hospitalization costs associated with treating bleeds in older adults with…
While patient-reported measures can provide valuable insight into an individual’s experience with hemophilia, a study suggests they may not…
Although it’s often mistakenly thought of as a male disease, hemophilia affects a substantial number of women and girls,…
The European Commission has approved Hympavzi (marstacimab) to treat certain people with hemophilia A or hemophilia B…